nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—breast cancer—colon cancer	0.832	1	CtDrD
Letrozole—CYP2A6—Fluorouracil—colon cancer	0.059	0.719	CbGbCtD
Letrozole—CYP3A4—Irinotecan—colon cancer	0.0123	0.15	CbGbCtD
Letrozole—CYP3A4—Vincristine—colon cancer	0.0107	0.131	CbGbCtD
Letrozole—Mental disorder—Vincristine—colon cancer	0.000229	0.00267	CcSEcCtD
Letrozole—Neoplasm—Methotrexate—colon cancer	0.000229	0.00266	CcSEcCtD
Letrozole—Dry skin—Capecitabine—colon cancer	0.000226	0.00263	CcSEcCtD
Letrozole—Alopecia—Irinotecan—colon cancer	0.000225	0.00262	CcSEcCtD
Letrozole—Breast disorder—Capecitabine—colon cancer	0.000223	0.00259	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000222	0.00258	CcSEcCtD
Letrozole—Back pain—Vincristine—colon cancer	0.00022	0.00256	CcSEcCtD
Letrozole—Alopecia—Fluorouracil—colon cancer	0.000216	0.00251	CcSEcCtD
Letrozole—Back pain—Irinotecan—colon cancer	0.000215	0.0025	CcSEcCtD
Letrozole—Influenza—Capecitabine—colon cancer	0.000213	0.00248	CcSEcCtD
Letrozole—Thrombophlebitis—Methotrexate—colon cancer	0.000212	0.00247	CcSEcCtD
Letrozole—Sweating increased—Capecitabine—colon cancer	0.000208	0.00242	CcSEcCtD
Letrozole—Angina pectoris—Capecitabine—colon cancer	0.000208	0.00242	CcSEcCtD
Letrozole—Ill-defined disorder—Irinotecan—colon cancer	0.000206	0.0024	CcSEcCtD
Letrozole—Vertigo—Vincristine—colon cancer	0.000205	0.00238	CcSEcCtD
Letrozole—Leukopenia—Vincristine—colon cancer	0.000204	0.00237	CcSEcCtD
Letrozole—Vision blurred—Fluorouracil—colon cancer	0.0002	0.00233	CcSEcCtD
Letrozole—Malaise—Irinotecan—colon cancer	0.0002	0.00233	CcSEcCtD
Letrozole—Vertigo—Irinotecan—colon cancer	0.000199	0.00232	CcSEcCtD
Letrozole—Leukopenia—Irinotecan—colon cancer	0.000199	0.00231	CcSEcCtD
Letrozole—Hypertension—Vincristine—colon cancer	0.000197	0.00229	CcSEcCtD
Letrozole—Myalgia—Vincristine—colon cancer	0.000194	0.00226	CcSEcCtD
Letrozole—Weight increased—Capecitabine—colon cancer	0.000194	0.00226	CcSEcCtD
Letrozole—Cough—Irinotecan—colon cancer	0.000194	0.00225	CcSEcCtD
Letrozole—Weight decreased—Capecitabine—colon cancer	0.000193	0.00224	CcSEcCtD
Letrozole—Hypertension—Irinotecan—colon cancer	0.000192	0.00223	CcSEcCtD
Letrozole—Leukopenia—Fluorouracil—colon cancer	0.00019	0.00221	CcSEcCtD
Letrozole—Infestation—Capecitabine—colon cancer	0.00019	0.00221	CcSEcCtD
Letrozole—Infestation NOS—Capecitabine—colon cancer	0.00019	0.00221	CcSEcCtD
Letrozole—Depression—Capecitabine—colon cancer	0.000189	0.00221	CcSEcCtD
Letrozole—Acute coronary syndrome—Capecitabine—colon cancer	0.000187	0.00218	CcSEcCtD
Letrozole—Cerebrovascular accident—Methotrexate—colon cancer	0.000187	0.00218	CcSEcCtD
Letrozole—Lethargy—Methotrexate—colon cancer	0.000187	0.00218	CcSEcCtD
Letrozole—Discomfort—Irinotecan—colon cancer	0.000187	0.00217	CcSEcCtD
Letrozole—Myocardial infarction—Capecitabine—colon cancer	0.000186	0.00217	CcSEcCtD
Letrozole—Oedema—Vincristine—colon cancer	0.000186	0.00216	CcSEcCtD
Letrozole—Anaphylactic shock—Vincristine—colon cancer	0.000186	0.00216	CcSEcCtD
Letrozole—Stomatitis—Capecitabine—colon cancer	0.000185	0.00216	CcSEcCtD
Letrozole—Infection—Vincristine—colon cancer	0.000185	0.00215	CcSEcCtD
Letrozole—Urinary tract infection—Capecitabine—colon cancer	0.000185	0.00215	CcSEcCtD
Letrozole—Nervous system disorder—Vincristine—colon cancer	0.000182	0.00212	CcSEcCtD
Letrozole—Anaphylactic shock—Irinotecan—colon cancer	0.000181	0.00211	CcSEcCtD
Letrozole—Oedema—Irinotecan—colon cancer	0.000181	0.00211	CcSEcCtD
Letrozole—Chest pain—Fluorouracil—colon cancer	0.000181	0.00211	CcSEcCtD
Letrozole—Myalgia—Fluorouracil—colon cancer	0.000181	0.00211	CcSEcCtD
Letrozole—Infection—Irinotecan—colon cancer	0.00018	0.00209	CcSEcCtD
Letrozole—Hyperhidrosis—Vincristine—colon cancer	0.00018	0.00209	CcSEcCtD
Letrozole—Hepatobiliary disease—Capecitabine—colon cancer	0.00018	0.00209	CcSEcCtD
Letrozole—Discomfort—Fluorouracil—colon cancer	0.000179	0.00208	CcSEcCtD
Letrozole—Nervous system disorder—Irinotecan—colon cancer	0.000178	0.00207	CcSEcCtD
Letrozole—Anorexia—Vincristine—colon cancer	0.000177	0.00206	CcSEcCtD
Letrozole—Irritability—Methotrexate—colon cancer	0.000175	0.00204	CcSEcCtD
Letrozole—Hyperhidrosis—Irinotecan—colon cancer	0.000175	0.00204	CcSEcCtD
Letrozole—Anaphylactic shock—Fluorouracil—colon cancer	0.000173	0.00202	CcSEcCtD
Letrozole—Oedema—Fluorouracil—colon cancer	0.000173	0.00202	CcSEcCtD
Letrozole—Anorexia—Irinotecan—colon cancer	0.000173	0.00201	CcSEcCtD
Letrozole—Infection—Fluorouracil—colon cancer	0.000172	0.00201	CcSEcCtD
Letrozole—Haemoglobin—Capecitabine—colon cancer	0.000171	0.002	CcSEcCtD
Letrozole—Hepatitis—Capecitabine—colon cancer	0.000171	0.00199	CcSEcCtD
Letrozole—Haemorrhage—Capecitabine—colon cancer	0.000171	0.00199	CcSEcCtD
Letrozole—Nervous system disorder—Fluorouracil—colon cancer	0.00017	0.00198	CcSEcCtD
Letrozole—Hypoaesthesia—Capecitabine—colon cancer	0.00017	0.00198	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000169	0.00197	CcSEcCtD
Letrozole—Tachycardia—Fluorouracil—colon cancer	0.000169	0.00197	CcSEcCtD
Letrozole—Urinary tract disorder—Capecitabine—colon cancer	0.000168	0.00196	CcSEcCtD
Letrozole—Insomnia—Vincristine—colon cancer	0.000168	0.00196	CcSEcCtD
Letrozole—Oedema peripheral—Capecitabine—colon cancer	0.000168	0.00196	CcSEcCtD
Letrozole—Connective tissue disorder—Capecitabine—colon cancer	0.000168	0.00195	CcSEcCtD
Letrozole—Urethral disorder—Capecitabine—colon cancer	0.000167	0.00195	CcSEcCtD
Letrozole—Paraesthesia—Vincristine—colon cancer	0.000167	0.00194	CcSEcCtD
Letrozole—Breast disorder—Methotrexate—colon cancer	0.000166	0.00193	CcSEcCtD
Letrozole—Anorexia—Fluorouracil—colon cancer	0.000165	0.00192	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000165	0.00192	CcSEcCtD
Letrozole—Insomnia—Irinotecan—colon cancer	0.000164	0.00191	CcSEcCtD
Letrozole—Paraesthesia—Irinotecan—colon cancer	0.000163	0.00189	CcSEcCtD
Letrozole—Decreased appetite—Vincristine—colon cancer	0.000162	0.00188	CcSEcCtD
Letrozole—Dyspnoea—Irinotecan—colon cancer	0.000161	0.00188	CcSEcCtD
Letrozole—Erythema multiforme—Capecitabine—colon cancer	0.000161	0.00188	CcSEcCtD
Letrozole—Somnolence—Irinotecan—colon cancer	0.000161	0.00187	CcSEcCtD
Letrozole—Gastrointestinal disorder—Vincristine—colon cancer	0.00016	0.00187	CcSEcCtD
Letrozole—Fatigue—Vincristine—colon cancer	0.00016	0.00187	CcSEcCtD
Letrozole—Eye disorder—Capecitabine—colon cancer	0.000159	0.00186	CcSEcCtD
Letrozole—Dyspepsia—Irinotecan—colon cancer	0.000159	0.00186	CcSEcCtD
Letrozole—Pain—Vincristine—colon cancer	0.000159	0.00185	CcSEcCtD
Letrozole—Constipation—Vincristine—colon cancer	0.000159	0.00185	CcSEcCtD
Letrozole—Flushing—Capecitabine—colon cancer	0.000158	0.00184	CcSEcCtD
Letrozole—Cardiac disorder—Capecitabine—colon cancer	0.000158	0.00184	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000158	0.00184	CcSEcCtD
Letrozole—Decreased appetite—Irinotecan—colon cancer	0.000157	0.00183	CcSEcCtD
Letrozole—Insomnia—Fluorouracil—colon cancer	0.000157	0.00183	CcSEcCtD
Letrozole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000156	0.00182	CcSEcCtD
Letrozole—Fatigue—Irinotecan—colon cancer	0.000156	0.00182	CcSEcCtD
Letrozole—Paraesthesia—Fluorouracil—colon cancer	0.000156	0.00181	CcSEcCtD
Letrozole—Constipation—Irinotecan—colon cancer	0.000155	0.0018	CcSEcCtD
Letrozole—Pain—Irinotecan—colon cancer	0.000155	0.0018	CcSEcCtD
Letrozole—Angiopathy—Capecitabine—colon cancer	0.000155	0.0018	CcSEcCtD
Letrozole—Dyspnoea—Fluorouracil—colon cancer	0.000155	0.0018	CcSEcCtD
Letrozole—Somnolence—Fluorouracil—colon cancer	0.000154	0.00179	CcSEcCtD
Letrozole—Mediastinal disorder—Capecitabine—colon cancer	0.000154	0.00179	CcSEcCtD
Letrozole—Dyspepsia—Fluorouracil—colon cancer	0.000153	0.00178	CcSEcCtD
Letrozole—Gastrointestinal pain—Vincristine—colon cancer	0.000152	0.00177	CcSEcCtD
Letrozole—Decreased appetite—Fluorouracil—colon cancer	0.000151	0.00175	CcSEcCtD
Letrozole—Alopecia—Capecitabine—colon cancer	0.000151	0.00175	CcSEcCtD
Letrozole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00015	0.00174	CcSEcCtD
Letrozole—Mental disorder—Capecitabine—colon cancer	0.000149	0.00174	CcSEcCtD
Letrozole—Feeling abnormal—Irinotecan—colon cancer	0.000149	0.00174	CcSEcCtD
Letrozole—Malnutrition—Capecitabine—colon cancer	0.000148	0.00173	CcSEcCtD
Letrozole—Pain—Fluorouracil—colon cancer	0.000148	0.00173	CcSEcCtD
Letrozole—Gastrointestinal pain—Irinotecan—colon cancer	0.000148	0.00172	CcSEcCtD
Letrozole—Abdominal pain—Vincristine—colon cancer	0.000147	0.00171	CcSEcCtD
Letrozole—Body temperature increased—Vincristine—colon cancer	0.000147	0.00171	CcSEcCtD
Letrozole—Dysgeusia—Capecitabine—colon cancer	0.000145	0.00169	CcSEcCtD
Letrozole—Back pain—Capecitabine—colon cancer	0.000144	0.00167	CcSEcCtD
Letrozole—Abdominal pain—Irinotecan—colon cancer	0.000143	0.00167	CcSEcCtD
Letrozole—Body temperature increased—Irinotecan—colon cancer	0.000143	0.00167	CcSEcCtD
Letrozole—Feeling abnormal—Fluorouracil—colon cancer	0.000143	0.00166	CcSEcCtD
Letrozole—Infestation—Methotrexate—colon cancer	0.000141	0.00165	CcSEcCtD
Letrozole—Infestation NOS—Methotrexate—colon cancer	0.000141	0.00165	CcSEcCtD
Letrozole—Depression—Methotrexate—colon cancer	0.000141	0.00164	CcSEcCtD
Letrozole—Vision blurred—Capecitabine—colon cancer	0.00014	0.00163	CcSEcCtD
Letrozole—Stomatitis—Methotrexate—colon cancer	0.000138	0.0016	CcSEcCtD
Letrozole—Ill-defined disorder—Capecitabine—colon cancer	0.000138	0.0016	CcSEcCtD
Letrozole—Urticaria—Fluorouracil—colon cancer	0.000138	0.0016	CcSEcCtD
Letrozole—Body temperature increased—Fluorouracil—colon cancer	0.000137	0.0016	CcSEcCtD
Letrozole—Sweating—Methotrexate—colon cancer	0.000136	0.00158	CcSEcCtD
Letrozole—Malaise—Capecitabine—colon cancer	0.000134	0.00156	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—colon cancer	0.000134	0.00156	CcSEcCtD
Letrozole—Vertigo—Capecitabine—colon cancer	0.000133	0.00155	CcSEcCtD
Letrozole—Asthenia—Vincristine—colon cancer	0.000133	0.00155	CcSEcCtD
Letrozole—Leukopenia—Capecitabine—colon cancer	0.000133	0.00155	CcSEcCtD
Letrozole—Palpitations—Capecitabine—colon cancer	0.000131	0.00153	CcSEcCtD
Letrozole—Asthenia—Irinotecan—colon cancer	0.00013	0.00151	CcSEcCtD
Letrozole—Cough—Capecitabine—colon cancer	0.00013	0.00151	CcSEcCtD
Letrozole—Hypertension—Capecitabine—colon cancer	0.000128	0.00149	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—colon cancer	0.000128	0.00149	CcSEcCtD
Letrozole—Diarrhoea—Vincristine—colon cancer	0.000127	0.00148	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—colon cancer	0.000127	0.00148	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—colon cancer	0.000127	0.00148	CcSEcCtD
Letrozole—Arthralgia—Capecitabine—colon cancer	0.000126	0.00147	CcSEcCtD
Letrozole—Chest pain—Capecitabine—colon cancer	0.000126	0.00147	CcSEcCtD
Letrozole—Myalgia—Capecitabine—colon cancer	0.000126	0.00147	CcSEcCtD
Letrozole—Anxiety—Capecitabine—colon cancer	0.000126	0.00147	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000126	0.00146	CcSEcCtD
Letrozole—Urinary tract disorder—Methotrexate—colon cancer	0.000125	0.00146	CcSEcCtD
Letrozole—Discomfort—Capecitabine—colon cancer	0.000125	0.00145	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—colon cancer	0.000124	0.00145	CcSEcCtD
Letrozole—Diarrhoea—Irinotecan—colon cancer	0.000124	0.00144	CcSEcCtD
Letrozole—Dry mouth—Capecitabine—colon cancer	0.000124	0.00144	CcSEcCtD
Letrozole—Dizziness—Vincristine—colon cancer	0.000123	0.00143	CcSEcCtD
Letrozole—Pruritus—Fluorouracil—colon cancer	0.000123	0.00143	CcSEcCtD
Letrozole—Oedema—Capecitabine—colon cancer	0.000121	0.00141	CcSEcCtD
Letrozole—Infection—Capecitabine—colon cancer	0.00012	0.0014	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—colon cancer	0.00012	0.0014	CcSEcCtD
Letrozole—Dizziness—Irinotecan—colon cancer	0.00012	0.00139	CcSEcCtD
Letrozole—Nervous system disorder—Capecitabine—colon cancer	0.000119	0.00138	CcSEcCtD
Letrozole—Eye disorder—Methotrexate—colon cancer	0.000119	0.00138	CcSEcCtD
Letrozole—Diarrhoea—Fluorouracil—colon cancer	0.000119	0.00138	CcSEcCtD
Letrozole—Tachycardia—Capecitabine—colon cancer	0.000118	0.00138	CcSEcCtD
Letrozole—Vomiting—Vincristine—colon cancer	0.000118	0.00138	CcSEcCtD
Letrozole—Cardiac disorder—Methotrexate—colon cancer	0.000118	0.00137	CcSEcCtD
Letrozole—Skin disorder—Capecitabine—colon cancer	0.000118	0.00137	CcSEcCtD
Letrozole—Rash—Vincristine—colon cancer	0.000117	0.00136	CcSEcCtD
Letrozole—Hyperhidrosis—Capecitabine—colon cancer	0.000117	0.00136	CcSEcCtD
Letrozole—Dermatitis—Vincristine—colon cancer	0.000117	0.00136	CcSEcCtD
Letrozole—Headache—Vincristine—colon cancer	0.000116	0.00136	CcSEcCtD
Letrozole—Anorexia—Capecitabine—colon cancer	0.000115	0.00134	CcSEcCtD
Letrozole—Angiopathy—Methotrexate—colon cancer	0.000115	0.00134	CcSEcCtD
Letrozole—Vomiting—Irinotecan—colon cancer	0.000115	0.00134	CcSEcCtD
Letrozole—Dizziness—Fluorouracil—colon cancer	0.000115	0.00133	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—colon cancer	0.000114	0.00133	CcSEcCtD
Letrozole—Rash—Irinotecan—colon cancer	0.000114	0.00133	CcSEcCtD
Letrozole—Dermatitis—Irinotecan—colon cancer	0.000114	0.00133	CcSEcCtD
Letrozole—Headache—Irinotecan—colon cancer	0.000113	0.00132	CcSEcCtD
Letrozole—Alopecia—Methotrexate—colon cancer	0.000112	0.00131	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—colon cancer	0.000111	0.00129	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—colon cancer	0.000111	0.00129	CcSEcCtD
Letrozole—Nausea—Vincristine—colon cancer	0.00011	0.00129	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00011	0.00129	CcSEcCtD
Letrozole—Vomiting—Fluorouracil—colon cancer	0.00011	0.00128	CcSEcCtD
Letrozole—Insomnia—Capecitabine—colon cancer	0.00011	0.00128	CcSEcCtD
Letrozole—Rash—Fluorouracil—colon cancer	0.000109	0.00127	CcSEcCtD
Letrozole—Dermatitis—Fluorouracil—colon cancer	0.000109	0.00127	CcSEcCtD
Letrozole—Paraesthesia—Capecitabine—colon cancer	0.000109	0.00127	CcSEcCtD
Letrozole—Headache—Fluorouracil—colon cancer	0.000109	0.00126	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—colon cancer	0.000108	0.00126	CcSEcCtD
Letrozole—Dyspnoea—Capecitabine—colon cancer	0.000108	0.00126	CcSEcCtD
Letrozole—Nausea—Irinotecan—colon cancer	0.000108	0.00125	CcSEcCtD
Letrozole—Back pain—Methotrexate—colon cancer	0.000107	0.00124	CcSEcCtD
Letrozole—Dyspepsia—Capecitabine—colon cancer	0.000107	0.00124	CcSEcCtD
Letrozole—Decreased appetite—Capecitabine—colon cancer	0.000105	0.00123	CcSEcCtD
Letrozole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000105	0.00122	CcSEcCtD
Letrozole—Fatigue—Capecitabine—colon cancer	0.000104	0.00122	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—colon cancer	0.000104	0.00121	CcSEcCtD
Letrozole—Constipation—Capecitabine—colon cancer	0.000104	0.00121	CcSEcCtD
Letrozole—Pain—Capecitabine—colon cancer	0.000104	0.00121	CcSEcCtD
Letrozole—Nausea—Fluorouracil—colon cancer	0.000103	0.0012	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—colon cancer	0.000103	0.00119	CcSEcCtD
Letrozole—Feeling abnormal—Capecitabine—colon cancer	9.98e-05	0.00116	CcSEcCtD
Letrozole—Malaise—Methotrexate—colon cancer	9.97e-05	0.00116	CcSEcCtD
Letrozole—Vertigo—Methotrexate—colon cancer	9.93e-05	0.00116	CcSEcCtD
Letrozole—Gastrointestinal pain—Capecitabine—colon cancer	9.91e-05	0.00115	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—colon cancer	9.89e-05	0.00115	CcSEcCtD
Letrozole—Cough—Methotrexate—colon cancer	9.64e-05	0.00112	CcSEcCtD
Letrozole—Urticaria—Capecitabine—colon cancer	9.63e-05	0.00112	CcSEcCtD
Letrozole—Abdominal pain—Capecitabine—colon cancer	9.58e-05	0.00111	CcSEcCtD
Letrozole—Body temperature increased—Capecitabine—colon cancer	9.58e-05	0.00111	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—colon cancer	9.41e-05	0.0011	CcSEcCtD
Letrozole—Chest pain—Methotrexate—colon cancer	9.41e-05	0.0011	CcSEcCtD
Letrozole—Myalgia—Methotrexate—colon cancer	9.41e-05	0.0011	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.34e-05	0.00109	CcSEcCtD
Letrozole—Discomfort—Methotrexate—colon cancer	9.3e-05	0.00108	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—colon cancer	9.02e-05	0.00105	CcSEcCtD
Letrozole—Infection—Methotrexate—colon cancer	8.96e-05	0.00104	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—colon cancer	8.85e-05	0.00103	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—colon cancer	8.76e-05	0.00102	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—colon cancer	8.72e-05	0.00102	CcSEcCtD
Letrozole—Asthenia—Capecitabine—colon cancer	8.69e-05	0.00101	CcSEcCtD
Letrozole—Anorexia—Methotrexate—colon cancer	8.6e-05	0.001	CcSEcCtD
Letrozole—Pruritus—Capecitabine—colon cancer	8.57e-05	0.000998	CcSEcCtD
Letrozole—Diarrhoea—Capecitabine—colon cancer	8.29e-05	0.000965	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—colon cancer	8.22e-05	0.000957	CcSEcCtD
Letrozole—Insomnia—Methotrexate—colon cancer	8.16e-05	0.00095	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—colon cancer	8.1e-05	0.000943	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—colon cancer	8.04e-05	0.000936	CcSEcCtD
Letrozole—Somnolence—Methotrexate—colon cancer	8.02e-05	0.000933	CcSEcCtD
Letrozole—Dizziness—Capecitabine—colon cancer	8.01e-05	0.000933	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—colon cancer	7.94e-05	0.000924	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—colon cancer	7.84e-05	0.000913	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—colon cancer	7.79e-05	0.000906	CcSEcCtD
Letrozole—Fatigue—Methotrexate—colon cancer	7.78e-05	0.000905	CcSEcCtD
Letrozole—Pain—Methotrexate—colon cancer	7.71e-05	0.000898	CcSEcCtD
Letrozole—Vomiting—Capecitabine—colon cancer	7.7e-05	0.000897	CcSEcCtD
Letrozole—Rash—Capecitabine—colon cancer	7.64e-05	0.000889	CcSEcCtD
Letrozole—Dermatitis—Capecitabine—colon cancer	7.63e-05	0.000888	CcSEcCtD
Letrozole—Headache—Capecitabine—colon cancer	7.59e-05	0.000884	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—colon cancer	7.43e-05	0.000865	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—colon cancer	7.38e-05	0.000859	CcSEcCtD
Letrozole—Nausea—Capecitabine—colon cancer	7.2e-05	0.000838	CcSEcCtD
Letrozole—Urticaria—Methotrexate—colon cancer	7.17e-05	0.000834	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—colon cancer	7.13e-05	0.00083	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—colon cancer	7.13e-05	0.00083	CcSEcCtD
Letrozole—Asthenia—Methotrexate—colon cancer	6.47e-05	0.000753	CcSEcCtD
Letrozole—Pruritus—Methotrexate—colon cancer	6.38e-05	0.000743	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—colon cancer	6.17e-05	0.000718	CcSEcCtD
Letrozole—Dizziness—Methotrexate—colon cancer	5.96e-05	0.000694	CcSEcCtD
Letrozole—Vomiting—Methotrexate—colon cancer	5.73e-05	0.000668	CcSEcCtD
Letrozole—Rash—Methotrexate—colon cancer	5.69e-05	0.000662	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—colon cancer	5.68e-05	0.000661	CcSEcCtD
Letrozole—Headache—Methotrexate—colon cancer	5.65e-05	0.000658	CcSEcCtD
Letrozole—Nausea—Methotrexate—colon cancer	5.36e-05	0.000624	CcSEcCtD
